SI-BONE Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: SI-BONE Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation: Delaware
Headquarters city: Santa Clara
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: SIBN
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0001459839
EIN: 26-2216351
Wikidata ID: Q106411740

Board of directors

Follow this board

Daniel W. Wolf · Director
Since 2024
Gregory K. Hinckley · Director
Since 2023
Helen Loh · Director
Since 2023
Jeffrey W. Dunn · Director
Since 2023
Jeryl L. Hilleman · Director
Since 2023
John Gordon Freund · Director
Since 2023
Keith Valentine · Director
Since 2023
Laura Francis · Director · Chief Executive Officer
Since 2023
Mika Nishimura · Director
Since 2023
Thomas A. West · Director
Since 2024
Timothy E. Davis Jr. · Director
Since 2023

Chief executives

Laura Francis · Chief Executive Officer

Dates unknown

Director election results

Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Jeffrey W. Dunn

63.4%

Board connections

7 of this board's directors also sit on 13 other boards. 11 are in the same sector.

Shared director Other board Same sector

Orthofix Medical Inc. Same sector
via Keith Valentine and Thomas A. West
Accuray Incorporated Same sector
via Mika Nishimura
Alphatec Holdings Inc. Same sector
via Keith Valentine
Bio-Rad Laboratories Inc.
via Gregory K. Hinckley
Bruker Corporation
via Laura Francis
CeriBell Inc. Same sector
via Thomas A. West
Collegium Pharmaceutical Inc. Same sector
via John Gordon Freund
Inogen Inc Same sector
via Thomas A. West
Minerva Neurosciences Inc Same sector
via Jeryl L. Hilleman
NovoCure Limited Same sector
via Jeryl L. Hilleman
Omada Health Inc. Same sector
via Jeryl L. Hilleman
Regentis Biomaterials Ltd. Same sector
via Keith Valentine
Sutro Biopharma Inc. Same sector
via John Gordon Freund

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $0; 0 purchases by 0 insiders
Sold, last 12 months: $13,421,976; 106 sales by 7 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 4, 2026	Laura Francis Director, Officer (Chief Executive Officer)	Open-market sale	−75,000	$25.30	$1,897,643
Nov 4, 2026	Maheshwari Anshul Officer (Chief Op & Financial Officer)	Open-market sale	−3,247	$25.00	$81,175
Nov 4, 2026	PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr)	Open-market sale	−36,241	$24.80	$898,802
Nov 2, 2026	Jeffrey W. Dunn Director	Option exercise	+20,000	$4.68	$93,600
Nov 2, 2026	Jeffrey W. Dunn Director	Open-market sale	−20,000	$20.89	$417,820
Oct 29, 2026	Maheshwari Anshul Officer (Chief Op & Financial Officer)	Open-market sale	−3,738	$22.50	$84,105
Oct 29, 2026	PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr)	Open-market sale	−29,665	$22.11	$655,745
Oct 5, 2026	Maheshwari Anshul Officer (Chief Op & Financial Officer)	Open-market sale	−1,731	$19.50	$33,755
Oct 2, 2026	Maheshwari Anshul Officer (Chief Op & Financial Officer)	Open-market sale	−1,560	$18.17	$28,341
Oct 2, 2026	PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr)	Open-market sale	−1,300	$18.20	$23,664
Oct 2, 2026	Maheshwari Anshul Officer (Chief Op & Financial Officer)	Open-market sale	−1,758	$18.19	$31,984
Oct 2, 2026	PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr)	Open-market sale	−1,799	$18.14	$32,637
Oct 2, 2026	PISETSKY MICHAEL A. Officer (SVP, Ops & Adm/Chief Legal Ofr)	Open-market sale	−34	$18.14	$617
Oct 1, 2026	Jeffrey W. Dunn Director	Option exercise	+20,000	$4.68	$93,600
Oct 1, 2026	Jeffrey W. Dunn Director	Open-market sale	−20,000	$18.47	$369,400

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about SI-BONE Inc.

Who is the CEO of SI-BONE Inc.?

Laura Francis is SI-BONE Inc.'s Chief Executive Officer.

How many directors are on SI-BONE Inc.'s board?

SI-BONE Inc.'s board has 11 directors: Daniel W. Wolf, Gregory K. Hinckley, Helen Loh, Jeffrey W. Dunn, Jeryl L. Hilleman, John Gordon Freund, Keith Valentine, Laura Francis, Mika Nishimura, Thomas A. West and 1 other.

Are SI-BONE Inc. insiders buying or selling shares?

Over the last 12 months, SI-BONE Inc. insiders made no open-market purchases and sold $13.4 million of shares in 106 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is SI-BONE Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="si-bone-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.